• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

全球左炔诺孕酮宫内节育系统（LNG IUS）学习议程：应对挑战和机遇，以增加其可及性。

A Global Learning Agenda for the Levonorgestrel Intrauterine System (LNG IUS): Addressing Challenges and Opportunities to Increase Access.

机构信息

FHI 360, Durham, NC, USA.

United States Agency for International Development (USAID), Washington, DC, USA.

出版信息

Glob Health Sci Pract. 2018 Dec 27;6(4):635-643. doi: 10.9745/GHSP-D-18-00383.

DOI:10.9745/GHSP-D-18-00383
PMID:30591573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6370355/
Abstract

The LNG IUS is one of the most effective forms of reversible contraception and has important noncontraceptive benefits but is currently not used at scale in any Family Planning 2020 focus country. A global working group developed a shared learning agenda to answer critical questions, harmonize approaches, avoid duplication, and facilitate introduction of the method within the context of informed choice.

摘要

LNG IUS 是最有效的可逆避孕方法之一，具有重要的非避孕益处，但目前在任何计划生育 2020 年重点国家都没有大规模使用。一个全球工作组制定了共同学习议程，以回答关键问题、协调方法、避免重复，并在知情选择的背景下促进该方法的引入。

相似文献

1
A Global Learning Agenda for the Levonorgestrel Intrauterine System (LNG IUS): Addressing Challenges and Opportunities to Increase Access.全球左炔诺孕酮宫内节育系统（LNG IUS）学习议程：应对挑战和机遇，以增加其可及性。
Glob Health Sci Pract. 2018 Dec 27;6(4):635-643. doi: 10.9745/GHSP-D-18-00383.
2
The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception.左炔诺孕酮宫内节育系统避孕的益处和风险。
Contraception. 2012 Mar;85(3):224-34. doi: 10.1016/j.contraception.2011.08.003. Epub 2011 Sep 19.
3
Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners.肯尼亚左炔诺孕酮宫内节育系统的使用经验：对使用者及其伴侣的定性访谈
Eur J Contracept Reprod Health Care. 2018 Aug;23(4):303-308. doi: 10.1080/13625187.2018.1499892. Epub 2018 Sep 10.
4
Expanding Access to a New, More Affordable Levonorgestrel Intrauterine System in Kenya: Service Delivery Costs Compared With Other Contraceptive Methods and Perspectives of Key Opinion Leaders.肯尼亚扩大新型、更实惠左炔诺孕酮宫内节育系统的使用：服务提供成本与其他避孕方法的比较以及主要意见领袖的观点。
Glob Health Sci Pract. 2016 Aug 18;4 Suppl 2(Suppl 2):S83-93. doi: 10.9745/GHSP-D-15-00327. Print 2016 Aug 11.
5
Experiences With the Levonorgestrel Intrauterine System Among Clients, Providers, and Key Opinion Leaders: A Mixed-Methods Study in Nigeria.《尼日利亚客户、提供者和主要意见领袖使用左炔诺孕酮宫内节育系统的经验：一项混合方法研究》
Glob Health Sci Pract. 2018 Dec 27;6(4):680-692. doi: 10.9745/GHSP-D-18-00242.
6
A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.一项多中心、开放标签、随机III期研究，比较一种新型左炔诺孕酮宫内节育系统（LNG-IUS 8）与复方口服避孕药在育龄年轻女性中的效果。
Eur J Contracept Reprod Health Care. 2016 Oct;21(5):372-9. doi: 10.1080/13625187.2016.1212987. Epub 2016 Aug 5.
7
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助他莫昔芬治疗的乳腺癌女性的子宫内膜保护
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007245. doi: 10.1002/14651858.CD007245.pub2.
8
Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.左炔诺孕酮宫内节育系统（LNG-IUS 12）用于长达五年的避孕。
Expert Rev Clin Pharmacol. 2017 Aug;10(8):833-842. doi: 10.1080/17512433.2017.1341308. Epub 2017 Jun 19.
9
LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years.左炔诺孕酮宫内缓释系统12型：一种含19.5毫克左炔诺孕酮的宫内缓释系统，可预防妊娠长达五年。
Expert Opin Drug Deliv. 2017 Sep;14(9):1131-1140. doi: 10.1080/17425247.2017.1353972. Epub 2017 Aug 2.
10
The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.左炔诺孕酮宫内节育系统：肯尼亚产后人群满意度评估队列研究。
Contraception. 2015 Apr;91(4):295-300. doi: 10.1016/j.contraception.2015.01.009. Epub 2015 Jan 16.

引用本文的文献

1
Depression risk in users of different doses of levonorgestrel intrauterine systems: a nationwide prospective cohort study.不同剂量左炔诺孕酮宫内节育系统使用者的抑郁风险：一项全国性前瞻性队列研究。
Lancet Reg Health Eur. 2024 Jan 5;38:100813. doi: 10.1016/j.lanepe.2023.100813. eCollection 2024 Mar.
2
Use of a hybrid digital training approach for hormonal IUD providers in Nigeria: results from a mixed method study.在尼日利亚使用混合数字培训方法对激素宫内节育器提供者进行培训：一项混合方法研究的结果。
BMC Health Serv Res. 2023 Nov 29;23(1):1316. doi: 10.1186/s12913-023-10211-5.
3
Defining Collective Priorities: Research and Learning Agendas for Family Planning Across 6 Countries.定义集体优先事项：6 个国家计划生育的研究和学习议程。
Glob Health Sci Pract. 2023 Aug 28;11(4). doi: 10.9745/GHSP-D-22-00469.
4
What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device.我们学到了什么？激素宫内节育器共享学习议程和获取策略的实施。
Glob Health Sci Pract. 2022 Oct 31;10(5). doi: 10.9745/GHSP-D-21-00789.
5
Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities.长效宫内节育系统：最新进展、当前挑战与未来机遇。
Adv Drug Deliv Rev. 2022 Dec;191:114581. doi: 10.1016/j.addr.2022.114581. Epub 2022 Oct 19.
6
IUD self-removal as self-care: Research is needed in low and middle-income countries.作为自我保健的宫内节育器自行取出：低收入和中等收入国家需要开展研究。
Front Glob Womens Health. 2022 Sep 7;3:992639. doi: 10.3389/fgwh.2022.992639. eCollection 2022.
7
What are the prospects for the hormonal IUD in the public sector? A mixed-method study of the user population in Zambia.宫内节育器在公共部门的前景如何？赞比亚使用者人群的混合方法研究。
BMC Womens Health. 2022 May 15;22(1):178. doi: 10.1186/s12905-022-01745-7.
8
Introducing the hormonal Intrauterine Device in Madagascar, Nigeria, and Zambia: results from a pilot study.在马达加斯加、尼日利亚和赞比亚引入激素宫内节育器：一项试点研究的结果。
Reprod Health. 2022 Jan 6;19(1):4. doi: 10.1186/s12978-021-01300-x.
9
Factors affecting uptake of the levonorgestrel-releasing intrauterine device: A mixed-method study of social franchise clients in Nigeria.影响左炔诺孕酮宫内节育器使用率的因素：尼日利亚社会特许经营客户的混合方法研究。
PLoS One. 2021 Sep 29;16(9):e0257769. doi: 10.1371/journal.pone.0257769. eCollection 2021.
10
Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia.扩大长效避孕选择：尼日利亚和赞比亚的激素宫内节育器、铜宫内节育器和植入物的前瞻性队列研究。
Lancet Glob Health. 2021 Oct;9(10):e1431-e1441. doi: 10.1016/S2214-109X(21)00318-1. Epub 2021 Aug 30.

本文引用的文献

1
Experiences With the Levonorgestrel Intrauterine System Among Clients, Providers, and Key Opinion Leaders: A Mixed-Methods Study in Nigeria.《尼日利亚客户、提供者和主要意见领袖使用左炔诺孕酮宫内节育系统的经验：一项混合方法研究》
Glob Health Sci Pract. 2018 Dec 27;6(4):680-692. doi: 10.9745/GHSP-D-18-00242.
2
Menstrual Bleeding Changes Are NORMAL: Proposed Counseling Tool to Address Common Reasons for Non-Use and Discontinuation of Contraception.经前期出血改变是正常的：提出咨询工具以解决常见的避孕方法不使用和停止使用的原因。
Glob Health Sci Pract. 2018 Oct 4;6(3):603-610. doi: 10.9745/GHSP-D-18-00093. Print 2018 Oct 3.
3
An Integrated Population Pharmacokinetic Analysis to Characterize Levonorgestrel Pharmacokinetics After Different Administration Routes.经不同给药途径后的左炔诺孕酮药代动力学特征的综合群体药代动力学分析。
J Clin Pharmacol. 2018 Dec;58(12):1639-1654. doi: 10.1002/jcph.1288. Epub 2018 Sep 12.
4
Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners.肯尼亚左炔诺孕酮宫内节育系统的使用经验：对使用者及其伴侣的定性访谈
Eur J Contracept Reprod Health Care. 2018 Aug;23(4):303-308. doi: 10.1080/13625187.2018.1499892. Epub 2018 Sep 10.
5
There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes.可能会有出血：关于女性对避孕引起的月经出血变化反应的范围综述。
Reprod Health. 2018 Jun 26;15(1):114. doi: 10.1186/s12978-018-0561-0.
6
Expanding Method Choice in Africa with Long-Acting Methods: IUDs, Implants or Both?扩大非洲长效避孕方法选择：宫内节育器、皮下埋植剂还是两者皆选？
Int Perspect Sex Reprod Health. 2017 Dec 1;43(4):183-191. doi: 10.1363/43e5217.
7
Historical record-setting trends in IUD use in the United States.美国宫内节育器（IUD）使用情况创历史记录的趋势。
Contraception. 2018 Dec;98(6):467-470. doi: 10.1016/j.contraception.2018.05.016. Epub 2018 May 26.
8
Liftoff: The Blossoming of Contraceptive Implant Use in Africa.启动：非洲避孕植入物使用的蓬勃发展。
Glob Health Sci Pract. 2018 Mar 30;6(1):17-39. doi: 10.9745/GHSP-D-17-00396. Print 2018 Mar 21.
9
Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling.美国食品和药物管理局标签规定的有效期之外，依托孕烯植入剂和 20μg 左炔诺孕酮宫内节育系统的延长有效性：2 年。
Glob Health Sci Pract. 2017 Dec 28;5(4):534-539. doi: 10.9745/GHSP-D-17-00296.
10
Expanding Access to a New, More Affordable Levonorgestrel Intrauterine System in Kenya: Service Delivery Costs Compared With Other Contraceptive Methods and Perspectives of Key Opinion Leaders.肯尼亚扩大新型、更实惠左炔诺孕酮宫内节育系统的使用：服务提供成本与其他避孕方法的比较以及主要意见领袖的观点。
Glob Health Sci Pract. 2016 Aug 18;4 Suppl 2(Suppl 2):S83-93. doi: 10.9745/GHSP-D-15-00327. Print 2016 Aug 11.